Primary
Pharmaceuticals, Medical Devices, Global Healthcare, Biotechnology
Former Chairman and CEO / Johnson & Johnson
Alex Gorsky is the former Chairman and CEO of Johnson & Johnson, where he served for over three decades, including ten years as CEO. During his tenure, he oversaw the development of life-saving cancer therapies, the deployment of Ebola vaccines, and the rapid development of the Janssen COVID-19 vaccine. He currently serves on the Boards of Directors for Apple and IBM and is a General Partner at ICONIQ Capital.
Twitter162
LinkedIn68.4KCo-Founder
General Partner
Former Chairman and CEO, Johnson & Johnson
Executive Chairman, Johnson & Johnson
Chairman of the Board and Chief Executive Officer
MBA
Bachelor of Science - BS
Core professional and domain-specific competencies developed over three decades of executive leadership in healthcare and technology.
Pharmaceuticals, Medical Devices, Global Healthcare, Biotechnology
Venture Capital, Technology, Digital Health, AI in Medicine
Visionary, Strategic, Credo-Driven, Results-Oriented, Military Discipline
Health Equity, Innovation, Global Impact, Corporate Responsibility
Factual questions and answers regarding Alex Gorsky's executive career at Johnson & Johnson and his current board and investment roles.
Yes, he currently serves on the Boards of Directors for both Apple and IBM, following his departure from his executive role at Johnson & Johnson.
He is a General Partner at ICONIQ Capital, a role he took on in 2024 after stepping down from his executive position at J&J.
The development of the Janssen COVID-19 vaccine was completed in 13 months under his leadership at Johnson & Johnson.
Yes, he is an alumnus of the United States Military Academy at West Point and also holds an MBA from The Wharton School.